Literature DB >> 11144474

Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand.

L L Johnson1, L Schofield, P Mastrofrancesco, T Donahay, A Farb, B A Khaw.   

Abstract

BACKGROUND: Glucarate is a 6-carbon dicarboxylic acid shown to be taken up by necrotic myocytes, binding to nuclear histones in animal models of coronary occlusion, resulting in infarction. This study investigated glucarate uptake in a model of severe ischemia. METHODS AND
RESULTS: Thirty-five experiments were performed, in which a catheter-mounted stenosis (reducing lumen dimensions by 80%) was placed in the left anterior descending coronary artery (LAD) of an anesthetized, instrumented domestic swine and technetium-99m glucarate (GLU) was injected during the last minute of 5 minutes of pacing. Hemodynamic and blood flow measurements were performed at control, during pacing, and during recovery. The animals were killed; their hearts were stained with fluorescein dye and triphenyl tetrazolium chloride (TTC). Electron micography (EM; n = 6) and cell centrifugation (n = 7) were also performed. On the basis of net lactate production and severe blood flow reduction in the risk region (RR), ischemia with pacing developed in 25 animals. Fifteen of 25 animals showed tracer uptake in the RR on in vivo and ex vivo imaging (scan positive), and 10 were scan negative in the RR. Endocardial blood flow in the RR during pacing was 0.28+/-0.16 mL/g/min for scan-positive and 0.30+/-0.17 mL/g/min for scan-negative experiments (P = not significant [NS]). Transmyocardial net lactate extraction during pacing was -63%+/-44% for scan-positive and -53%+/-60% for scan-negative experiments (P = NS). Control and recovery heart rates were higher in scan-positive experiments (108+/-14 vs. 92+/-17, and 125+/-24 vs. 104+/-18, P<.02). Lactate extraction was lower during control and recovery in scan-positive animals (2+/-29 vs. 30+/-19, P = .03). Scan-positive animals had a more proximal stenosis position. Minimal necrosis was documented by means of TTC negative staining in 8 of 15 scan-positive experiments (comprising 10%+/-4.3% of RR area). EM or cell fractionation was performed in 5 of the 7 remaining scan-positive and TTC-positive hearts, and in those 5 experiments, necrosis was documented by means of EM in 2 and by means of cell fractionation in 3.
CONCLUSIONS: Uptake of Tc-99m glucarate was seen in the RR in a swine model of ischemia severe enough to produce myocyte injury and early cell death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11144474     DOI: 10.1067/mnc.2000.108908

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  10 in total

1.  Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment.

Authors:  B A Khaw; A Nakazawa; S M O'Donnell; K Y Pak; J Narula
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

2.  Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics.

Authors:  R S Beanlands; T D Ruddy; L Bielawski; H Johansen
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

3.  Production of a critical coronary arterial stenosis in closed chest laboratory animals. Description of a new nonsurgical method based on standard cardiac catheterization techniques.

Authors:  H Gewirtz; A S Most
Journal:  Am J Cardiol       Date:  1981-03       Impact factor: 2.778

4.  Localization of technetium-99m-glucarate in zones of acute cerebral injury.

Authors:  H Yaoita; T Uehara; A L Brownell; C A Rabito; M Ahmad; B A Khaw; A J Fischman; H W Strauss
Journal:  J Nucl Med       Date:  1991-02       Impact factor: 10.057

5.  Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with 99mTc-labeled glucarate.

Authors:  J Narula; A Petrov; K Y Pak; B C Lister; B A Khaw
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

6.  Early detection and measurement of experimental myocardial infarcts with horseradish peroxidase.

Authors:  A Farb; F D Kolodgie; R M Jones; M Jenkins; R Virmani
Journal:  J Mol Cell Cardiol       Date:  1993-04       Impact factor: 5.000

7.  Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium.

Authors:  H Yaoita; A J Fischman; R Wilkinson; B A Khaw; M Juweid; H W Strauss
Journal:  J Nucl Med       Date:  1993-08       Impact factor: 10.057

8.  Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique.

Authors:  M C Fishbein; S Meerbaum; J Rit; U Lando; K Kanmatsuse; J C Mercier; E Corday; W Ganz
Journal:  Am Heart J       Date:  1981-05       Impact factor: 4.749

9.  Evaluation of nonradioactive, colored microspheres for measurement of regional myocardial blood flow in dogs.

Authors:  S L Hale; K J Alker; R A Kloner
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

10.  Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid.

Authors:  C Orlandi; P D Crane; D S Edwards; S H Platts; L Bernard; J Lazewatsky; M J Thoolen
Journal:  J Nucl Med       Date:  1991-02       Impact factor: 10.057

  10 in total
  11 in total

1.  99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model.

Authors:  David R Okada; Zhonglin Liu; Gerald Johnson; Delia Beju; Ban An Khaw; Robert D Okada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-24       Impact factor: 9.236

2.  Technetium 99m glucarate: what will be its clinical role?

Authors:  M C Gerson; A J McGoron
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

3.  Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia.

Authors:  D R Okada; G Johnson; Z Liu; S D Hocherman; B A Khaw; K Y Pak; R D Okada
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

4.  (99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium.

Authors:  Gerald Johnson; Christine C Okada; Sonia D Hocherman; Zhonglin Liu; Curtis Hart; Ban-An Khaw; Robert D Okada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-20       Impact factor: 9.236

5.  Evaluating the protective role of ischaemic preconditioning in rat hearts using a stationary small-animal SPECT imager and 99mTc-glucarate.

Authors:  Zhonglin Liu; Harrison H Barrett; Gail D Stevenson; Lars R Furenlid; Koon Yan Pak; James M Woolfenden
Journal:  Nucl Med Commun       Date:  2008-02       Impact factor: 1.690

Review 6.  Use of radionuclide imaging in acute coronary syndromes.

Authors:  Brian G Abbott; Frans J Wackers
Journal:  Curr Cardiol Rep       Date:  2003-01       Impact factor: 2.931

7.  High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion.

Authors:  Zhonglin Liu; Harrison H Barrett; Gail D Stevenson; George A Kastis; Michael Bettan; Lars R Furenlid; Donald W Wilson; Koon Yan Pak
Journal:  J Nucl Med       Date:  2004-07       Impact factor: 10.057

Review 8.  Non-invasive in vivo imaging of myocardial apoptosis and necrosis.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-14       Impact factor: 9.236

9.  Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardium.

Authors:  Lynne L Johnson; Lorraine Schofield; Tammy Donahay; Mark Bouchard; Athena Poppas; Roland Haubner
Journal:  JACC Cardiovasc Imaging       Date:  2008-07

Review 10.  Untiring Pursuit for Glucarate-Based Molecular Imaging Probes.

Authors:  Dongjian Zhang; Qiaomei Jin; Meng Gao; Cuihua Jiang; Yicheng Ni; Jian Zhang
Journal:  Mol Imaging Biol       Date:  2020-11-18       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.